285 Results

People

  1. Seidman
    Seidman
  2. Hudis
    Hudis
  3. Kris
    Kris
  4. Aghajanian
    Aghajanian
  5. Bajorin
    Bajorin
  6. Fornier
    Fornier
  7. Kelsen
    Kelsen
  8. Lichtman
    Lichtman
  9. Scher
    Scher
  10. Iasonos
    Iasonos

Groups

  1. Department of Medicine (179)
  2. Solid Tumor Oncology Division (149)
  3. Survivorship Research (64)
  4. Surgery (47)
  5. Breast Medicine Service (45)
  6. Epidemiology and Biostatistics (42)
  7. Biostatistics Service (38)
  8. Hematologic Malignancies, Division of (35)
  9. Genitourinary Oncology Service (32)
  10. Population Sciences Research Program (29)
  1. "neuropathy"
Formats
  1. Journal Article (274)
  2. Review (4)
  3. Book Section (3)
  4. Editorial (2)
  5. Meeting Abstract (1)
  6. Research Letter (1)
Groups
  1. Department of Medicine (179)
  2. Solid Tumor Oncology Division (149)
  3. Survivorship Research (64)
  4. Surgery (47)
  5. Breast Medicine Service (45)
  6. Epidemiology and Biostatistics (42)

More Groups

People
  1. Andrew Seidman (20)
  2. Clifford Hudis (17)
  3. Mark Kris (13)
  4. Carol Aghajanian (12)
  5. Dean Bajorin (12)
  6. David Kelsen (10)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (7)
  5. 2021 (4)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Cancer (14)
  3. Gynecologic Oncology (11)
  4. Clinical Cancer Research (10)
  5. Seminars in Oncology (10)
  6. The Oncologist (8)

More Publications

Publishers
  1. Elsevier Inc. (62)
  2. Springer (30)
  3. American Society of Clinical Oncology (21)
  4. Oxford University Press (21)
  5. Wiley Blackwell (18)
  6. Elsevier Science, Inc. (16)

More Publishers

Results (285)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies
    Journal Article

    Ailawadhi, S.; Biru, Y.; Clavreul, S.; Miguel, M. S.; Cormier, N.; Efebera, Y.; Merz, M.; Sato, A.; Zeanah, C.; Watkins, J. L.; more...
    Patient Preference and Adherence (2025)

    Fulltext@MSK | Save
  • Urine-free response criteria predict progression-free survival in multiple myeloma: A post hoc analysis of BMT CTN 0702
    Research Letter

    Banerjee, R.; Fritz, A. R.; Akhtar, O. S.; Freeman, C. L.; Cowan, A. J.; Shah, N.; Landau, H. J.; Kumar, S. K.; Vogl, D. T.; Efebera, Y. A.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Strengthening medical imaging capacity: The time is now
    Editorial

    Hricak, H.; Prior, J. O.; Muellner, A.; Abdel-Wahab, M.; Allen, B.; Atun, R.; Cerri, G. G.; Ngwa, W.; Hierath, M.; Scott, A. M.
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes of definitive radiotherapy vs. laryngectomy followed by adjuvant radiotherapy in patients with locally advanced laryngeal squamous cell carcinoma: Real-world experience in a referral cancer center
    Journal Article

    Kazemian, A.; Esmati, E.; Ghalehtaki, R.; Farazmand, B.; Mousavi-Darzikolaee, N.; Bayani, R.; Razmkhah, M.; Taherioun, M.; Saeedi, N.; Heidari, F.; more...
    Radiation Oncology (2024)

    Fulltext@MSK | Save
  • Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial
    Journal Article

    Sun, L.; Xu, Y.; Chen, N.; Zhang, C.; Wu, A.; Wang, H.; Fei, Y.; Shu, P.; Diao, D.; Cheng, J.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin as initial salvage chemotherapy for germ cell tumors: Long-term follow-up and outcomes for favorable- and unfavorable-risk disease
    Journal Article

    Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Bains, M.; Jones, D. R.; Bajorin, D. F.; Bosl, G. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study
    Journal Article

    Nooka, A. K.; Kaufman, J. L.; Rodriguez, C.; Jakubowiak, A.; Efebera, Y.; Reeves, B.; Wildes, T. M.; Holstein, S. A.; Anderson, L. D. Jr; Badros, A.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Combined hepatic arterial infusion pump and systemic chemotherapy in the modern era for chemotherapy-naive patients with unresectable colorectal liver metastases
    Journal Article

    Verheij, F. S.; Kuhlmann, K. F. D.; Silliman, D. R.; Soares, K. C.; Kingham, T. P.; Balachandran, V. P.; Drebin, J. A.; Wei, A. C.; Jarnagin, W. R.; Cercek, A.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Patient perceptions regarding ciltacabtagene autoleucel treatment: Qualitative evidence from interviews with patients with relapsed/refractory multiple myeloma in the CARTITUDE-1 study
    Journal Article

    Cohen, A. D.; Hari, P.; Htut, M.; Berdeja, J. G.; Usmani, S. Z.; Madduri, D.; Olyslager, Y.; Goldberg, J. D.; Schecter, J. M.; Jackson, C. C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save